Yeah there is something fishy here. There is ample evidence of anti competitive behaviour. TM/LN are well known in the industry as being bullies. This should be a slam dunk case for someone who really wanted to chase it.
The resale market at minimum should be separated, if not the ticketing from the touring side.
I trust they considered the bias in medical research that exists in their training. I wonder if OpenAI will implement morbidity & mortality (M&M) rounds to learn from the mistakes and missed diagnosis.
Based on the reports of various failings on the safety front, I sure hope users will take that into account before they get advice to take 500g of aspirin.
The resale market at minimum should be separated, if not the ticketing from the touring side.